Aspirin/Caffeine/Orphenadrine Citrate

阿司匹林/咖啡因/枸橼酸奥芬那君

Report date: 2024/08/20 20:00:16
NME

Base Information

Drug NameAspirin/Caffeine/Orphenadrine Citrate
Drug Alias NameNorgesicNorgesic Forte
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists +[5] 
TargetsCyclooxygenasesAdenosine A1 receptorAdenosine A2a receptor +[5] 
Therapy Area/IndicationsPain
Global Approved IndicationsPain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1964/03/04
Country/TerritoryUnited States
CombinationsYes AspirinCaffeineOrphenadrine Citrate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBausch Health Us Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBausch Health Us Llc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A